Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

DGAP-News: United Internet gets off to good start in 2022: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24075/330px-UnitedInternet_logo.svg.png
DGAP-News: United Internet gets off to good start in 2022
DGAP-News: United Internet gets off to good start in 2022
DGAP-News: Bechtle delivers impressive Q1 performance: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24050/225px-Bechtle_AG_20xx_logo.svg.png
DGAP-News: Bechtle delivers impressive Q1 performance
DGAP-News: Bechtle delivers impressive Q1 performance
DGAP-News: VARTA AG: VARTA AG remains committed to annual  targets despite global crises: https://upload.wikimedia.org/wikipedia/commons/thumb/1/13/Varta-Logo.svg/1000px-Varta-Logo.svg.png
DGAP-News: VARTA AG: VARTA AG remains committed to annual targets despite global crises
DGAP-News: VARTA AG: VARTA AG remains committed to annual targets despite global crises
DGAP-News: Telefónica Deutschland Holding AG: Strong start to FY22 – ongoing profitable growth momentum building on network parity and ESG-leadership: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24073/Telefonica_Logo.svg.png
DGAP-News: Telefónica Deutschland Holding AG: Strong start to FY22 – ongoing profitable growth momentum building on network parity and ESG-leadership
DGAP-News: Telefónica Deutschland Holding AG: Strong start to FY22 – ongoing profitable growth momentum building on network parity and ESG-leadership
DGAP-News: Evotec SE reports results for the first quarter 2022 and provides corporate update: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: Evotec SE reports results for the first quarter 2022 and provides corporate update
DGAP-News: Evotec SE reports results for the first quarter 2022 and provides corporate update
DGAP-News: Evotec and Bristol Myers Squibb extend and expand strategic partnership in protein degradation: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: Evotec and Bristol Myers Squibb extend and expand strategic partnership in protein degradation
DGAP-News: Evotec and Bristol Myers Squibb extend and expand strategic partnership in protein degradation
DGAP-News: Siltronic AG reports very good Q1 and expects positive business development for 2022: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24068/Siltronic_Logo.svg.png
DGAP-News: Siltronic AG reports very good Q1 and expects positive business development for 2022
DGAP-News: Siltronic AG reports very good Q1 and expects positive business development for 2022
DGAP-News: freenet AG: Marc Tüngler elected as new Chairman of the Supervisory Board of freenet AG: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24058/375px-Freenet_AG_Logo.svg.png
DGAP-News: freenet AG: Marc Tüngler elected as new Chairman of the Supervisory Board of freenet AG
DGAP-News: freenet AG: Marc Tüngler elected as new Chairman of the Supervisory Board of freenet AG
DGAP-News: freenet AG: Annual General Meeting approves annual dividend of 1.57 euros per share (previous year: 1.50 euros): http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24058/375px-Freenet_AG_Logo.svg.png
DGAP-News: freenet AG: Annual General Meeting approves annual dividend of 1.57 euros per share (previous year: 1.50 euros)
DGAP-News: freenet AG: Annual General Meeting approves annual dividend of 1.57 euros per share (previous year: 1.50 euros)
DGAP-News: MorphoSys AG Reports First Quarter 2022 Financial Results: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
DGAP-News: MorphoSys AG Reports First Quarter 2022 Financial Results
DGAP-News: MorphoSys AG Reports First Quarter 2022 Financial Results
DGAP-News: Evotec SE to announce results for the first quarter 2022 on 11 May 2022: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: Evotec SE to announce results for the first quarter 2022 on 11 May 2022
DGAP-News: Evotec SE to announce results for the first quarter 2022 on 11 May 2022
DGAP-News: CANCOM SE: Satisfactory earnings development despite revenue decline in the first quarter of 2022. Annual forecast now more defensive.: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24051/375px-PLAN._BUILT._PERFORM..png
DGAP-News: CANCOM SE: Satisfactory earnings development despite revenue decline in the first quarter of 2022. Annual forecast now more defensive.
DGAP-News: CANCOM SE: Satisfactory earnings development despite revenue decline in the first quarter of 2022. Annual forecast now more defensive.
DGAP-Adhoc: CANCOM SE: Preliminary figures for first quarter 2022 show revenue down 10.8 percent but EBITDA up 6.2 percent. Executive Board lowers forecast for 2022.: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24051/375px-PLAN._BUILT._PERFORM..png
DGAP-Adhoc: CANCOM SE: Preliminary figures for first quarter 2022 show revenue down 10.8 percent but EBITDA up 6.2 percent. Executive Board lowers forecast for 2022.
DGAP-Adhoc: CANCOM SE: Preliminary figures for first quarter 2022 show revenue down 10.8 percent but EBITDA up 6.2 percent. Executive Board lowers forecast for 2022.
DGAP-News: Invitation to MorphoSys' First Quarter 2022 Financial Results Conference Call on May 5, 2022: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
DGAP-News: Invitation to MorphoSys' First Quarter 2022 Financial Results Conference Call on May 5, 2022
DGAP-News: Invitation to MorphoSys' First Quarter 2022 Financial Results Conference Call on May 5, 2022
DGAP-News: Nemetschek Group: Strong start to 2022 with high double-digit revenue growth and increased profitability: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24062/Nemetschek_AG_Logo.svg.png
DGAP-News: Nemetschek Group: Strong start to 2022 with high double-digit revenue growth and increased profitability
DGAP-News: Nemetschek Group: Strong start to 2022 with high double-digit revenue growth and increased profitability
DGAP-Adhoc: Bechtle AG: Q1 EBT very significantly above expectations: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24050/225px-Bechtle_AG_20xx_logo.svg.png
DGAP-Adhoc: Bechtle AG: Q1 EBT very significantly above expectations
DGAP-Adhoc: Bechtle AG: Q1 EBT very significantly above expectations
DGAP-Adhoc: QIAGEN N.V.: QIAGEN increases full-year 2022 outlook: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24065/Qiagen_Logo.svg.png
DGAP-Adhoc: QIAGEN N.V.: QIAGEN increases full-year 2022 outlook
DGAP-Adhoc: QIAGEN N.V.: QIAGEN increases full-year 2022 outlook
DGAP-News: 1&1 signs further contract with a leading tower company: American Tower Corporation to partner in the roll-out of the 1&1 mobile network: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24057/Drillisch_AG_Logo.svg.png
DGAP-News: 1&1 signs further contract with a leading tower company: American Tower Corporation to partner in the roll-out of the 1&1 mobile network
DGAP-News: 1&1 signs further contract with a leading tower company: American Tower Corporation to partner in the roll-out of the 1&1 mobile network
DGAP-Adhoc: Nagarro SE: Increase in guidance for FY 2022: https://upload.wikimedia.org/wikipedia/commons/0/0a/Nagarro_Horizontal_Light_400x100px_300dpi.png
DGAP-Adhoc: Nagarro SE: Increase in guidance for FY 2022
DGAP-Adhoc: Nagarro SE: Increase in guidance for FY 2022
Nemetschek: Erfolgsstory setzt sich weiter fort, doch...
Nemetschek: Erfolgsstory setzt sich weiter fort, doch...

Größter Gewinner im TecDAX ist heute die Aktie des Bau- und Architektursoftwarespezialisten Nemetschek (WKN: 645290). Grund hierfür sind nicht die heute vorgelegten ansehnlichen Quartalszahlen

Varta: Gut, besser, Varta!
Varta: Gut, besser, Varta!

Beeindruckende Q1-Zahlen verkündete Varta (WKN: A0TGJ5) am 15. Mai (wir berichteten). Im Anschluss gewann die Aktie von 74,70 Euro auf momentan 92,55 Euro über 20% hinzu. Geht es so rasant weiter?

MorphoSys: Dieser Rücksetzer ist kaufenswert!
MorphoSys: Dieser Rücksetzer ist kaufenswert!

Die in Martinsried bei München beheimatete MorphoSys (WKN: 663200) ist aus meiner Sicht, zusammen mit der Hamburger Evotec, das beste deutsche Biotechnologieunternehmen.

Dies konnte man auch erst

Sartorius: Unternehmen profitiert von der Corona-Krise
Sartorius: Unternehmen profitiert von der Corona-Krise

Ein absoluter Highflyer am deutschen Aktienmarkt ist schon seit vielen Jahren die Vorzugsaktie des Göttinger Laborausrüsters Sartorius (WKN: 716563). Dies ist umso erstaunlicher, da noch zu Neuer

EQS-News: TeamViewer extends CFO contract with Michael Wilkens, CCO Peter Turner to leave the Management Board at the end of his term
EQS-News: TeamViewer extends CFO contract with Michael Wilkens, CCO Peter Turner to leave the Management Board at the end of his term
EQS-News: TeamViewer extends CFO contract with Michael Wilkens, CCO Peter Turner to leave the Management Board at the end of his term
EQS-News: CompuGroup Medical appoints Prof. Dr. Daniel Gotthardt as new CEO
EQS-News: CompuGroup Medical appoints Prof. Dr. Daniel Gotthardt as new CEO
EQS-News: CompuGroup Medical appoints Prof. Dr. Daniel Gotthardt as new CEO